Literature DB >> 12432222

Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth.

H-S Yu1.   

Abstract

Melanocytes (MCs) are melanin-producing cells of the skin that are derived from neural crest cells. Vitiligo vulgaris is a common depigmentation disorder resulting from the destruction of functional MCs in the affected skin. The three prevailing pathomechanisms of vitiligo are the immune hypothesis, the neural hypothesis and the autocytotoxic hypothesis. None of these mechanisms has been conclusively proven. Melanoblasts (MBs) in the outer root sheath of the hair follicles are the reservoir cells for repigmentation. Recovery from vitiligo is initiated by activation and proliferation of these MBs, followed by upward migration to the nearby epidermis that forms perifollicular pigmentation islands. Migration, proliferation and differentiation of MCs and MBs are regulated by keratinocyte-derived factors and some coat color genes. Any therapy for vitiligo must explain not only the repopulation of MCs but also their functional development. In patients with vitiligo, MCs are destroyed in the skin, the eyes, and possibly the ears. However, the concept of vitiligo as a systemic disease will be clearly established only when the mechanisms involved in vitiligo are identified. Recent advances in the fields of neural crest cell culture and molecular genetics have opened new perspectives in the understanding of vitiligo. Not only will this result in better treatments for vitiligo patients, but possibly will also provide a key to triggering nerve cell regrowth in other nervous diseases. Copyright 2002 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12432222     DOI: 10.1159/000067283

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  7 in total

Review 1.  Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes.

Authors:  Igor Adameyko; Francois Lallemend
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

2.  Targeted Broadband UVB Phototherapy forthe Treatment of Localized Vitiligo.

Authors:  Jeong Eun Kim; Hyo Hyun Ahn; Young Chul Kye
Journal:  Ann Dermatol       Date:  2008-09-30       Impact factor: 1.444

3.  Aquaporin 3 and E-Cadherin Expression in Perilesional Vitiligo Skin.

Authors:  Ola Ahmed Bakry; Magda Mostafa Hagag; Mona Abd El Halim Kandil; Wafaa Ahmed Shehata
Journal:  J Clin Diagn Res       Date:  2016-12-01

Review 4.  Cancer stem cells and human malignant melanoma.

Authors:  Tobias Schatton; Markus H Frank
Journal:  Pigment Cell Melanoma Res       Date:  2008-02       Impact factor: 4.693

Review 5.  Stem cells in melanoma development.

Authors:  Marianna Sabatino; David F Stroncek; Harvey Klein; Francesco M Marincola; Ena Wang
Journal:  Cancer Lett       Date:  2008-12-17       Impact factor: 8.679

6.  In situ quantification of individual mRNA transcripts in melanocytes discloses gene regulation of relevance to speciation.

Authors:  Chi-Chih Wu; Axel Klaesson; Julia Buskas; Petter Ranefall; Reza Mirzazadeh; Ola Söderberg; Jochen B W Wolf
Journal:  J Exp Biol       Date:  2019-03-08       Impact factor: 3.312

7.  Early acquisition of neural crest competence during hESCs neuralization.

Authors:  Carol Lynn Curchoe; Jochen Maurer; Sonja J McKeown; Giulio Cattarossi; Flavio Cimadamore; Mats Nilbratt; Evan Y Snyder; Marianne Bronner-Fraser; Alexey V Terskikh
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.